Other Transaction Agreement HR0011269E094
- Not listed
- This is a $149,661.75 firm-fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer. The contract is for the development of a next-generation cell-free prototyping and biomanufacturing platform. Biodiscovery LLC, a subsidiary of the Japanese chemical company Daicel Corporation, specializes in custom molecular...
- This is a firm fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Synvitrobio, Inc. (doing business as Tierra Biosciences), a minority-owned small business, in the amount of $149,999.91. The contract is for the development of "rapid, reliable and repeatable platforms for cell-free prototyping", which supports DARPA's work in biosystems research and materials innovations for the military. Synvitrobio...
- Boundless Science Inc., a small business innovator in advanced medical device research and development, was awarded a definitive firm fixed-price contract by the Defense Advanced Research Projects Agency (DARPA) on January 30, 2025, with a ceiling value of $3.9 million. Designated as a total small business set-aside, the contract calls for the development of a Novel Blood Oxygenation Device designed to save warriors on the battlefield, with completion scheduled for August 2, 2026. The Durham,...
- This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
- This is a $224,995.00 STTR Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Brimrose Technology Corp, a for-profit company specializing in advanced material science and innovation. The contract is for the development of a multimodal non-destructive microfluidic sorting system for microbes, to support elemental analysis. This award was made under a DARPA Broad Agency Announcement seeking small business innovation in areas aligned with DARPA's mission, including...
- This is a Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Other Lab, Inc., a small business, on March 25, 2016 for $3,947,198.00. The contract is for a "BTO STUDY - COMPLIANT MATERIAL SIMULATION AND DEVELOPMENT ENVIRONMENT" related to DARPA's Biological Technologies Office (BTO) and was awarded under DARPA-BAA-15-35. The contract has an ultimate completion date of March 29, 2019 and does not have a set-aside designation. Other Lab,...
- Battelle Memorial Institute, a Columbus, Ohio-based nonprofit research and development organization with over 20,000 employees, was awarded a $10.05 million cost-plus-fixed-fee definitive contract by the Defense Advanced Research Projects Agency (DARPA) on February 5, 2024. The contract, with an ultimate completion date of October 4, 2028, supports a DARPA research program and is not associated with a set-aside designation, reflecting Battelle's competitive capabilities in full and open...
- This is a $5,828,149.00 cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Battelle Memorial Institute, a large non-profit research and development organization, for the "Assured Microbial Preservation in Harsh or Remote Areas (AMPHORA)" program. The contract, which does not have a set-aside designation, runs through July 30, 2027. The AMPHORA program aims to develop systems that can preserve a broad range of biological...
- The Office of the Assistant Secretary for Preparedness and Response awarded Biofire Defense LLC a $5.72 million cost-plus-fixed-fee definitive contract on September 19, 2022, for development of the IVD Warrior Panel Bridge for use on the BioFire FilmArray Torch instrument, with completion targeted for September 2027. This award emerged from a Biomedical Advanced Research and Development Authority broad agency announcement soliciting advanced research and development of medical countermeasures...
- The Defense Advanced Research Projects Agency (DARPA) awarded a $300,000 firm fixed-price definitive contract to Polaris Quantum Biotech Inc. on July 17, 2025, for work to be performed in Cary, North Carolina. This award stems from DARPA's Commercial Solutions Opening (CSO) solicitation posted in May 2024, which sought innovative commercial solutions derived from DARPA research and development programs to transition into operational capabilities. The contract represents Polaris Quantum Biotech's...
Bifrost Biosystems Inc., a for-profit bioengineering firm, was awarded an Other Transaction Agreement (OTA) by the Defense Advanced Research Projects Agency (DARPA) on February 9, 2026, for the VAULT (Versatile Athermic Unit for Long-Duration Transport) program, which supports high-throughput cell screening platforms. The contract, valued at approximately $1.95 million with completion targeted for August 9, 2027, will be performed in Berkeley, California. This award represents DARPA's continued investment in innovative cell biology technologies that advance the agency's mission of maintaining U.S. technological superiority. Under this contract, Bifrost Biosystems will further develop its integrated platform for high-throughput cellular interrogation and tracking, capable of monitoring up to one million separate cell lineages simultaneously while maintaining exceptional control over local conditions. The platform enables in situ genotyping, time-lapse imaging of individual cells, and terminal assays on tracked lineages—achieving throughput and resolution capabilities orders of magnitude beyond existing technologies. This work builds on prior Small Business Innovation Research funding from DARPA and collaborative development with Harvard University, positioning the technology to support broad applications in bioengineering and pathogen detection critical to defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3m | 2/3/26 |